Red Arrow Therapeutics Inc.

About Red Arrow Therapeutics Inc.

Red Arrow Therapeutics is a biopharmaceutical company focused on transforming proinflammatory biology into novel therapies for cancer patients. Their vision is to make nanopolymer drug delivery a proven, safe, and effective solution worldwide, while their mission is to save patients' lives with nanotechnology.

Products & Services

RA001:Lead asset, an interleukin-12 prodrug based on nanopolymer technology, with an IND planned for 2027.

Nanopolymer Drug Delivery Technology:Broad applicability in drug delivery, including small peptide to antibody full chain and cationic to anionic protein transformations.

Specialties

Nanopolymer Drug Delivery Cancer Immunotherapy Interleukin-12 Prodrug Technology pH-sensitive Polymeric Micelles

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed Extension T: - FT: Seed Extension	A: 4500000 MR: - FA: $4.5M FAN: 4500000	D: 2024-04-23 FD: 2024-04-23	4 investors

Seed Extension Latest

2024-04-23

$4.5M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Horacio Cabral

Co-founder, Drug Discovery Head

T

Takuya Miyazaki

Co-founder, Scientific Advisor

R

Rika Tajima

Recent News